GlassScriptPhysician profile
Brian D Pepe
NPI 1811949126
$860.22
in general payments reported to CMS, 2019-2025
12 companies · $551 in 2025
The $551 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $63.22 · 2022: $93.23 · 2023: $60.68 · 2024: $91.74 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $703.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $182.08 | 2025 | Sapien 3 Ultra Resilia |
| Pfizer INC. | $156.53 | 2022-2025 | |
| Glaxosmithkline, LLC. | $136.08 | 2021-2025 | Bexsero, Rotarix, Pediarix |
| Cranial Technologies, INC | $97.72 | 2021-2025 | Doc Band |
| Alk-Abello, INC | $76.55 | 2023-2025 | Neffy, Grastek, Odactra |
| Sanofi-Aventis U.S. LLC | $48.05 | 2025 | |
| Sanofi Pasteur INC. | $37.23 | 2022 | |
| Phadia US INC. | $36.44 | 2024-2025 | Immunocap |
| Seqirus USA INC | $32.91 | 2022-2025 | Flucelvax |
| Merck Sharp & Dohme LLC | $29.52 | 2022-2024 | Gardasil 9, Gardasil, M-M-R II |
| Ars Pharmaceuticals Operations, INC. | $13.60 | 2025 | Neffy |
| Collegium Pharmaceutical, INC. | $13.51 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Pepe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.